What You Should Know

• Virtual women’s health pioneer Teal Health has announced a strategic research collaboration with the Washington University School of Medicine in St. Louis to expand cervical cancer screening access.
• Orchestrated through the SCORE Initiative at Siteman Cancer Center, the pilot study targets women who have fallen out of touch with the traditional healthcare system and routine preventative care.
• The community-based distribution model deploys Teal Health’s FDA-authorized at-home HPV (human papillomavirus) self-collection kits across trusted spaces like health fairs, food banks, and wellness initiatives in Illinois and Missouri.
• The study evaluates two distinct participant onboarding workflows: a self-directed digital track where women enroll independently using a QR code, and a guided track featuring on-site navigators for real-time enrollment and education.
• Researchers will closely monitor metrics crucial to enterprise clinical validation, including kit return rates, telehealth completion, follow-up care engagement for abnormal results, and overall patient experience.

Moving Outside the Clinic: Why Teal Health and WashU Medicine Are Distributing At-Home HPV Kits via Food Banks

The preventative oncology sector is confronting an acute equity and access crisis within its clinical trial and screening pipelines. Despite decades of evidence proving that routine cervical cancer screenings significantly lower mortality rates, millions of women across the United States remain dangerously overdue for care. The legacy screening model relies heavily on traditional, in-office pelvic exams—a system that introduces severe structural friction for underserved populations. Obstacles like lack of transportation, child care constraints, clinic hours that conflict with hourly work shifts, and past medical mistrust frequently push vulnerable patients out of touch with routine preventative loops.

When women fall through these healthcare cracks, the clinical fallout is devastating. Cervical cancer is highly preventable when caught early, yet data fragmentation and rigid access models mean that diagnoses in underserved communities are often caught at advanced stages. For healthcare systems, academic medical centers, and Medicaid programs, resolving this gap requires moving past traditional campus-based medicine. Innovation must shift toward patient-centered, decentralized infrastructure that can safely meet individuals outside the clinic walls.

To bridge this data wall and build a community-directed system of action, virtual women’s health company Teal Health has finalized a strategic research collaboration with the Washington University School of Medicine in St. Louis. Led by the SCORE Initiative—a dedicated project to increase the uptake of recommended cancer screenings at Siteman Cancer Center based at Barnes-Jewish Hospital and WashU Medicine—the collaboration launches a new pilot study to evaluate a decentralized, community-based distribution framework for cervical cancer prevention.

Activating the Self-Collection Layer via Trusted Spaces

The operational differentiator of the Teal Health-WashU Medicine integration is its focus on utilizing established community trust to drive clinical engagement. Rather than waiting for high-risk patients to navigate complex hospital scheduling lines, the pilot study directly routes Teal Health’s FDA-authorized at-home HPV self-collection kits into local community spaces across Illinois and Missouri. Kits will be distributed at highly accessible, routine touchpoints, including local wellness initiatives, regional health fairs, and area food banks.

To optimize data collection and understand consumer behavior, the Institutional Review Board (IRB)-approved study is actively testing two distinct operational pathways:

• The Self-Directed Digital Track: Women independently enroll in the screening program and activate their profile on-site by scanning a localized QR code with their mobile device.
• The Guided Navigation Track: Specialized on-site medical navigators assist participants with real-time digital enrollment and deliver immediate clinical education during the community event.

By offering a private, comfortable alternative to traditional clinic exams, the platform removes the primary physical and psychological barriers to proactive screening. Researchers will comprehensively track and evaluate multiple backend workflow milestones to measure success: kit return rates, telehealth consultation completion, overall participant satisfaction, and follow-up care engagement timelines for patients returning abnormal results.

Kara Egan, CEO and co-founder of Teal Health, emphasized that for too long, cervical cancer screening has lacked the operational flexibility to easily fit into the realities of many women’s lives. The collaboration solves this friction by bringing advanced diagnostic capabilities into trusted community environments. This model provides a blueprint for a future where life-saving preventative care is genuinely accessible to everyone, everywhere.

Scaling Interoperable Prevention Across Medicaid Networks

For health plan administrators, academic networks, and community health organizations, the pilot delivers vital, real-world data on how to scale home-based diagnostic operations for historically hard-to-reach demographics. Nicole Miller, BSN, RN, an oncology nurse navigator from Siteman Cancer Network member Phelps Health in Rolla, Missouri, noted that integrating at-home self-collection directly enhances the standard of localized care. It provides a highly secure option for individuals who prefer privacy, serving as an important step toward ensuring cancer prevention is universally accessible.

Michelle Silver, PhD, ScM, an epidemiologist and health services research member at Siteman and associate professor at WashU Medicine, highlighted the broader implications of the study. Silver noted that the collaboration provides an invaluable, real-world lens into the precise mechanics required to engage women who have fallen through the traditional screening infrastructure. The data generated from this pilot could fundamentally reshape regional and national approaches to cervical cancer prevention.